188 related articles for article (PubMed ID: 26513019)
21. Ubiquitin carboxy-terminal hydrolase L1 binds to and stabilizes monoubiquitin in neuron.
Osaka H; Wang YL; Takada K; Takizawa S; Setsuie R; Li H; Sato Y; Nishikawa K; Sun YJ; Sakurai M; Harada T; Hara Y; Kimura I; Chiba S; Namikawa K; Kiyama H; Noda M; Aoki S; Wada K
Hum Mol Genet; 2003 Aug; 12(16):1945-58. PubMed ID: 12913066
[TBL] [Abstract][Full Text] [Related]
22. High Expression of Ubiquitin C-terminal Hydrolase L1 Is Associated With Poor Prognosis in Endometrial Cancer Patients.
Nakao K; Hirakawa T; Suwa H; Kogure K; Ikeda S; Yamashita S; Minegishi T; Kishi H
Int J Gynecol Cancer; 2018 May; 28(4):675-683. PubMed ID: 29489474
[TBL] [Abstract][Full Text] [Related]
23. Epigenetic identification of ubiquitin carboxyl-terminal hydrolase L1 as a functional tumor suppressor and biomarker for hepatocellular carcinoma and other digestive tumors.
Yu J; Tao Q; Cheung KF; Jin H; Poon FF; Wang X; Li H; Cheng YY; Röcken C; Ebert MP; Chan AT; Sung JJ
Hepatology; 2008 Aug; 48(2):508-18. PubMed ID: 18666234
[TBL] [Abstract][Full Text] [Related]
24. Ubiquitin carboxyl-terminal hydrolase L1, a novel deubiquitinating enzyme in the vasculature, attenuates NF-kappaB activation.
Takami Y; Nakagami H; Morishita R; Katsuya T; Cui TX; Ichikawa T; Saito Y; Hayashi H; Kikuchi Y; Nishikawa T; Baba Y; Yasuda O; Rakugi H; Ogihara T; Kaneda Y
Arterioscler Thromb Vasc Biol; 2007 Oct; 27(10):2184-90. PubMed ID: 17690318
[TBL] [Abstract][Full Text] [Related]
25. Overexpression of ubiquitin carboxyl-terminal hydrolase L1 arrests spermatogenesis in transgenic mice.
Wang YL; Liu W; Sun YJ; Kwon J; Setsuie R; Osaka H; Noda M; Aoki S; Yoshikawa Y; Wada K
Mol Reprod Dev; 2006 Jan; 73(1):40-9. PubMed ID: 16177983
[TBL] [Abstract][Full Text] [Related]
26. Ubiquitin carboxyl-terminal esterase L1 (UCHL1) is associated with stem-like cancer cell functions in pediatric high-grade glioma.
Sanchez-Diaz PC; Chang JC; Moses ES; Dao T; Chen Y; Hung JY
PLoS One; 2017; 12(5):e0176879. PubMed ID: 28472177
[TBL] [Abstract][Full Text] [Related]
27. Serum UCH-L1 as a Novel Biomarker to Predict Neuronal Apoptosis Following Deep Hypothermic Circulatory Arrest.
Zhang YP; Zhu YB; Duan DD; Fan XM; He Y; Su JW; Liu YL
Int J Med Sci; 2015; 12(7):576-82. PubMed ID: 26180514
[TBL] [Abstract][Full Text] [Related]
28. Localization of ubiquitin C-terminal hydrolase L1 in mouse ova and its function in the plasma membrane to block polyspermy.
Sekiguchi S; Kwon J; Yoshida E; Hamasaki H; Ichinose S; Hideshima M; Kuraoka M; Takahashi A; Ishii Y; Kyuwa S; Wada K; Yoshikawa Y
Am J Pathol; 2006 Nov; 169(5):1722-9. PubMed ID: 17071595
[TBL] [Abstract][Full Text] [Related]
29. Ubiquitin C-Terminal Hydrolase L1 regulates myoblast proliferation and differentiation.
Gao H; Hartnett S; Li Y
Biochem Biophys Res Commun; 2017 Oct; 492(1):96-102. PubMed ID: 28803986
[TBL] [Abstract][Full Text] [Related]
30. Progression signature underlies clonal evolution and dissemination of multiple myeloma.
Shen YJ; Mishima Y; Shi J; Sklavenitis-Pistofidis R; Redd RA; Moschetta M; Manier S; Roccaro AM; Sacco A; Tai YT; Mercier F; Kawano Y; Su NK; Berrios B; Doench JG; Root DE; Michor F; Scadden DT; Ghobrial IM
Blood; 2021 Apr; 137(17):2360-2372. PubMed ID: 33150374
[TBL] [Abstract][Full Text] [Related]
31. NF-κB signaling inhibits ubiquitin carboxyl-terminal hydrolase L1 gene expression.
Wang R; Zhang M; Zhou W; Ly PT; Cai F; Song W
J Neurochem; 2011 Mar; 116(6):1160-70. PubMed ID: 21210816
[TBL] [Abstract][Full Text] [Related]
32. Overexpression of salivary-type amylase reduces the sensitivity to bortezomib in multiple myeloma cells.
Mizuno S; Hanamura I; Ota A; Karnan S; Narita T; Ri M; Mizutani M; Goto M; Gotou M; Tsunekawa N; Shikami M; Iida S; Hosokawa Y; Miwa H; Ueda R; Nitta M; Takami A
Int J Hematol; 2015 Nov; 102(5):569-78. PubMed ID: 26341959
[TBL] [Abstract][Full Text] [Related]
33. Expression in the mammalian retina of parkin and UCH-L1, two components of the ubiquitin-proteasome system.
Esteve-Rudd J; Campello L; Herrero MT; Cuenca N; Martín-Nieto J
Brain Res; 2010 Sep; 1352():70-82. PubMed ID: 20638372
[TBL] [Abstract][Full Text] [Related]
34. CCR10/CCL27 crosstalk contributes to failure of proteasome-inhibitors in multiple myeloma.
Thangavadivel S; Zelle-Rieser C; Olivier A; Postert B; Untergasser G; Kern J; Brunner A; Gunsilius E; Biedermann R; Hajek R; Pour L; Willenbacher W; Greil R; Jöhrer K
Oncotarget; 2016 Nov; 7(48):78605-78618. PubMed ID: 27732933
[TBL] [Abstract][Full Text] [Related]
35. Cloning and expression analysis of a Parkinson's disease gene, uch-L1, and its promoter in zebrafish.
Son OL; Kim HT; Ji MH; Yoo KW; Rhee M; Kim CH
Biochem Biophys Res Commun; 2003 Dec; 312(3):601-7. PubMed ID: 14680807
[TBL] [Abstract][Full Text] [Related]
36. Homoharringtonine inhibits the AKT pathway and induces in vitro and in vivo cytotoxicity in human multiple myeloma cells.
Meng H; Yang C; Jin J; Zhou Y; Qian W
Leuk Lymphoma; 2008 Oct; 49(10):1954-62. PubMed ID: 18949618
[TBL] [Abstract][Full Text] [Related]
37. Endogenous neurotoxic dopamine derivative covalently binds to Parkinson's disease-associated ubiquitin C-terminal hydrolase L1 and alters its structure and function.
Contu VR; Kotake Y; Toyama T; Okuda K; Miyara M; Sakamoto S; Samizo S; Sanoh S; Kumagai Y; Ohta S
J Neurochem; 2014 Sep; 130(6):826-38. PubMed ID: 24832624
[TBL] [Abstract][Full Text] [Related]
38. Ubiquitin C-terminal hydrolase-L1 (UCH-L1) as a therapeutic and diagnostic target in neurodegeneration, neurotrauma and neuro-injuries.
Wang KK; Yang Z; Sarkis G; Torres I; Raghavan V
Expert Opin Ther Targets; 2017 Jun; 21(6):627-638. PubMed ID: 28434268
[TBL] [Abstract][Full Text] [Related]
39. Ubiquitin C-terminal hydrolase L1 deletion ameliorates glomerular injury in mice with ACTN4-associated focal segmental glomerulosclerosis.
Read NC; Gutsol A; Holterman CE; Carter A; Coulombe J; Gray DA; Kennedy CR
Biochim Biophys Acta; 2014 Jul; 1842(7):1028-40. PubMed ID: 24662305
[TBL] [Abstract][Full Text] [Related]
40. UCHL1 acts as a colorectal cancer oncogene via activation of the β-catenin/TCF pathway through its deubiquitinating activity.
Zhong J; Zhao M; Ma Y; Luo Q; Liu J; Wang J; Yuan X; Sang J; Huang C
Int J Mol Med; 2012 Aug; 30(2):430-6. PubMed ID: 22641175
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
